Anti-TNF- α Biologics Do Not Reverse CDX2 Downregulation in Patients with Crohn's Disease.

CONCLUSIONS: Although CDX2 is downregulated in CD, it did not revert to normal in patients treated with anti-TNF-α biologics.
PMID: 32366553 [PubMed - in process]

Source: Annals of Clinical and Laboratory Science - February 29, 2020 Category: Laboratory Medicine Authors: Younes M, Rahimi E, DuPont AW, Ly CJ, Ertan A Tags: Ann Clin Lab Sci Source Type: research